SCHEMBL24660946

SCHEMBL24660946

Cn1c(C(F)(F)C(C)(O)c2cccc(NC(=O)OC(C)(C)C)c2)n[nH]c1=S

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 1/20 0.46
▸ LMNA P02545 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ GFER P55789 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ ACSS2 Q9NR19 1/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ SYK P43405 1/20 0.38
▸ CYP17A1 P05093 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ EGFR P00533 1/20 0.36
▸ SRC P12931 1/20 0.36
▸ AURKA O14965 1/20 0.36
▸ RPS6KB1 P23443 1/20 0.36
▸ AURKB Q96GD4 1/20 0.36
▸ RORC P51449 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28940818 0.82 RXFP1 (0.45) RXFP1ALDH1A1ACSS2L3MBTL1SYK
SCHEMBL29626649 0.82 RXFP1 (0.45) RXFP1ALDH1A1ACSS2L3MBTL1SYK
SCHEMBL22944950 0.79 CBLB (0.52) RXFP1ACSS2SYKCYP17A1RORC
SCHEMBL29640156 0.79 CBLB (0.52) RXFP1ACSS2SYKCYP17A1RORC
SCHEMBL1013325 0.72 RXFP1 (0.73) RXFP1LMNAKDM4EALDH1A1L3MBTL1
SCHEMBL30042580 0.72 RXFP1 (0.73) RXFP1LMNAKDM4EALDH1A1L3MBTL1
SCHEMBL29626593 0.71 RXFP1 (0.52) RXFP1LMNAALDH1A1ACSS2L3MBTL1
SCHEMBL31091996 0.71 RXFP1 (0.52) RXFP1LMNAALDH1A1ACSS2L3MBTL1
SCHEMBL22944961 0.70 CBLB (0.62) RXFP1ACSS2RORC
SCHEMBL29640139 0.70 CBLB (0.62) RXFP1ACSS2RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022221704-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING CANCER HOTSPOT THERAPEUTICS, INC. (US) 2022-10-20 — — WO disclosed
Send feedback